Plus Therapeutics Inc (PSTV)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $26.64M
Last updated: Nov 16, 2026 at 4:00 PM ET
Plus Therapeutics Inc (PSTV) Stock Chart
Plus Therapeutics (PSTV) closed at $0.71 on Nov 16, 2026. Its price fell 94.5% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 70.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $333,583.21 in Oct 2016 and its lowest $1.70 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PSTV with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PSTV.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 76.8%, and over 6 months it fell 87.8%. The month-end price fell 94.4% over the 3 years through Oct 2026, a compound annual decline of 61.8%.
| Period | Change |
|---|---|
| 1 month | -58.0% |
| 3 months | -76.8% |
| 6 months | -87.8% |
| 12 months | -94.5% |
| 12 months, with dividends | -94.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -94.4% | -61.8% |
| 5 years | -99.8% | -70.1% |
| 10 years | -100.0% | -70.4% |
Price by Year
Its best calendar year was 2020, when the price fell 15.8%, and its weakest was 2018, when it fell 90.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.70 | -86.7% |
| 2025 | $12.81 | -55.5% |
| 2024 | $28.75 | -34.3% |
| 2023 | $43.75 | -63.2% |
| 2022 | $118.82 | -69.8% |
| 2021 | $393.55 | -48.0% |
| 2020 | $757.12 | -15.8% |
| 2019 | $899.55 | -83.4% |
| 2018 | $5,434.78 | -90.3% |
| 2017 | $56,221.89 | -80.1% |
Trading Range
The price is 57.0% below its 50-day average of $1.66 and 83.4% below its 200-day average of $4.31.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $0.71 | |
| 50-day average | $1.66 | -57.0% |
| 200-day average | $4.31 | -83.4% |
Price Risk
Over 3 years, its largest fall from a peak was 99.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.96 |
| Largest fall, 1 year | -96.8% |
| Largest fall, 3 years | -99.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PSTV
What is PSTV's 1-year price change?
Plus Therapeutics's price fell 94.5% over the past 12 months. With dividends included, the 12-month total return was -94.5%.
What is PSTV's 5-year price change?
Plus Therapeutics's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 70.1%. These figures leave out dividends.
What is PSTV's beta?
Plus Therapeutics's 1-year beta against the S&P 500 is 1.96, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 96.8%.
Is the PSTV chart free?
Yes. Advanced Charting for PSTV is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PSTV pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors